SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-15-005479
Filing Date
2015-12-10
Accepted
2015-12-10 16:16:32
Documents
11
Period of Report
2015-10-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT tenx_10q.htm 10-Q 744455
2 CERTIFICATION tenx_ex311.htm EX-31.1 13190
3 CERTIFICATION tenx_ex312.htm EX-31.2 13218
4 CERTIFICATION tenx_ex321.htm EX-32.1 6393
5 CERTIFICATION tenx_ex322.htm EX-32.2 7202
  Complete submission text file 0001354488-15-005479.txt   2508621

Data Files

Seq Description Document Type Size
6 tenx-20151031.xml EX-101.INS 366936
7 tenx-20151031.xsd EX-101.SCH 30273
8 tenx-20151031_cal.xml EX-101.CAL 38458
9 tenx-20151031_def.xml EX-101.DEF 34345
10 tenx-20151031_lab.xml EX-101.LAB 215236
11 tenx-20151031_pre.xml EX-101.PRE 135695
Mailing Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560
Business Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560 919-806-4414
TENAX THERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

IRS No.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34600 | Film No.: 151281038
SIC: 8731 Services-Commercial Physical & Biological Research